A Multicenter, Open-label, Pilot Study of Soticlestat (TAK-935/OV935) in Participants With 15Q Duplication Syndrome (Dup 15q) or Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder (ARCADE STUDY)

Name: A Multicenter, Open-label, Pilot Study of Soticlestat (TAK-935/OV935) in Participants With 15Q Duplication Syndrome (Dup 15q) or Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder (ARCADE STUDY)
Published: 2018
License: Public Domain

Takeda · 2018

ClinicalTrials.gov · Datasets · License: Public Domain · 2018

Open Source ↗

autism drug-therapy epilepsy

15q duplication syndrome, cdkl5 deficiency disease, drug therapy, 15q duplication syndrome (dup15q), cdkl5 deficiency disorder (cdd), brain diseases, epilepsy, central nervous system diseases, autism, cholesterol 24s-hydroxylase inhibitor, anti-epilepsy drug, anticonvulsants

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 968990
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.